Serum miR-21 expression in human esophageal squamous cell carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.
• Identifying reliable biomarkers for early diagnosis and prognosis is crucial for effective ESCC management.

Purpose of the Study:

• To investigate the association between serum microRNA-21 (miR-21) levels and clinicopathologic features in ESCC patients.
• To evaluate the potential of serum miR-21 as a diagnostic and prognostic biomarker for ESCC.

Main Methods:

• A case-control study involving 21 ESCC patients and 21 matched healthy controls.
• Serum samples were analyzed for miR-21 expression using stem-loop real-time polymerase chain reaction.
• Clinicopathologic data were collected and correlated with serum miR-21 concentrations.

Main Results:

• Serum miR-21 expression was significantly higher in ESCC patients compared to healthy controls (P <0.05).
• Metastasis was strongly associated with elevated serum miR-21 levels (P <0.05), with an 8.4-fold increase in metastatic cases.
• No significant associations were found between miR-21 levels and other clinicopathologic parameters like age, gender, tumor location, differentiation, TNM stage, or treatment status.

Conclusions:

• Serum miR-21 is a potential diagnostic biomarker for ESCC.
• Elevated serum miR-21 levels correlate with metastasis, suggesting its utility in prognosis assessment.
• Further research is warranted to validate serum miR-21 as a clinical tool for ESCC management.